Floatz logo

1,379 assets in Cancer

Therapeutic assets addressing Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
mq719
Cancer
Memorial Sloan Kettering Cancer CenterP1C (39)
Mrtx1719
Cancer
M.D. Anderson Cancer CenterP1C (39)
msp008-22
Cancer
Godavari Biorefineries LimitedP1C (39)
ntq1062
Cancer
Nanjing Chia-tai Tianqing PharmaceuticalP1C (39)
Oki-219
Cancer
OnKure, Inc.P1C (39)
Olomorasib
Cancer
Eli Lilly and CompanyP1C (39)
Pclx 001
Cancer
Pacylex PharmaceuticalsP1C (39)
Phn-012
Cancer
Pheon TherapeuticsP1C (39)
Ping-Hher3Fl
Cancer
Herbert LyerlyP1C (39)
Ptx-912
Cancer
Proviva Therapeutics, Inc.P1C (39)
rbs2418
Cancer
Riboscience, LLC.P1C (39)
ro7623066
Cancer
Hoffmann-La RocheP1C (39)
Senaparib
Cancer
Shanghai Junshi Bioscience Co., Ltd.P1C (39)
Serabelisib
Cancer
Faeth TherapeuticsP1C (39)
Shr-7631
Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P1C (39)
Shr-A2009
Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P1C (39)
sph5030
Cancer
Shanghai Pharmaceuticals Holding Co., LtdP1C (39)
Tach101
Cancer
Tachyon Therapeutics, Inc.P1C (39)
tj033721
Cancer
I-Mab Biopharma US LimitedP1C (39)
tt125-802
Cancer
TOLREMO therapeutics AGP1C (39)
yh002
Cancer
Eucure (Beijing) Biopharma Co., LtdP1C (39)
yh004
Cancer
Eucure (Beijing) Biopharma Co., LtdP1C (39)
yy001
Cancer
Shanghai Yuyao Biotech Co., Ltd.P1C (39)
Zggs15
Cancer
Suzhou Zelgen Biopharmaceuticals Co.,LtdP1C (39)
zl-1211
Cancer
Zai Biopharmaceutical (Suzhou) Co., Ltd.P1C (39)
Alteplase
Cancer
M.D. Anderson Cancer CenterEarly P1C (38)
Incb099280
Cancer
Incyte CorporationP2C (38)
Sasanlimab
Cancer
PfizerP1/2C (38)
agx101
Cancer
Angiex, Inc.P1C (37)
Allogeneic Nkg2Dl-Targeting Chimeric Antigen Receptor-Grafted Γδ T Cells
Cancer
CytoMed Therapeutics Pte LtdP1C (37)
Alta2618
Cancer
Alterome Therapeutics, Inc.P1C (37)
Alta3263
Cancer
Alterome Therapeutics, Inc.P1C (37)
Bnd-35
Cancer
Biond BiologicsP1C (37)
cpo301
Cancer
Conjupro Biotherapeutics, Inc.P1C (37)
Dfp-14927
Cancer
Delta-Fly Pharma, Inc.P1C (37)
dk210
Cancer
DEKA BiosciencesP1C (37)
Dxp-106
Cancer
Singlomics Biopharmaceuticals Zhuhai Co., Ltd.P1C (37)
Enoblituzumab
Cancer
Masonic Cancer Center, University of MinnesotaP1C (37)
Giloralimab
Cancer
AbbVieP1C (37)
Hbi-2376
Cancer
HUYABIO International, LLC.P1C (37)
Hbi-2438
Cancer
HUYABIO International, LLC.P1C (37)
Icovamenib
Cancer
Biomea Fusion Inc.P1C (37)
im-1617
Cancer
Immunome, Inc.P1C (37)
Inv-1120
Cancer
Shenzhen Ionova Life Sciences Co., Ltd.P1C (37)
jmt108
Cancer
Conjupro Biotherapeutics, Inc.P1C (37)
Mpd-1
Cancer
Pharosgen Co.,LtdP1C (37)
Ntx-1088
Cancer
Nectin Therapeutics LtdP1C (37)
Pan-Neovax
Cancer
West China HospitalP1C (37)
Revdofilimab
Cancer
AbbVieP1C (37)
Rndo-564
Cancer
Rondo TherapeuticsP1C (37)
Showing 801 to 850 of 1,379 assets
PreviousPage 17 of 28Next